GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Cash Flow from Discontinued Operations

Biomics Biopharma (ASX:BBM) Cash Flow from Discontinued Operations : A$0.00 Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Biomics Biopharma's cash flow from discontinued operations for the six months ended in . 20 was A$0.00 Mil. It means Biomics Biopharma received A$0.00 Mil from the sale of part of business quarterly. Biomics Biopharma's cash flow from discontinued operations for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

Biomics Biopharma Cash Flow from Discontinued Operations Historical Data

The historical data trend for Biomics Biopharma's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Cash Flow from Discontinued Operations Chart

Biomics Biopharma Annual Data
Trend
Cash Flow from Discontinued Operations

Biomics Biopharma Semi-Annual Data
Cash Flow from Discontinued Operations

Biomics Biopharma Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA
Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Website
http://www.biomics.com
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines